Glonghui, May 9 | According to the latest equity disclosure data on the Stock Exchange, on May 2, 2024, Luye Pharmaceutical (02186.HK) received UBS Group AG's good holdings of 3.569,500 shares at an average price of HK$2.9389 per share on the market, involving approximately HK$10.49 million.
After the increase in holdings, UBS Group AG's latest number of good positions was 452,878,777 shares, and the holding ratio increased from 11.94% to 12.04%.
